Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Aspirin responsiveness safely lowers perioperative cardiovascular risk.

Calderaro D, Pastana AF, Flores da Rocha TR, Yu PC, Gualandro DM, DeLuccia N, D' Amico EA, Caramelli B.

J Vasc Surg. 2013 Dec;58(6):1593-9. doi: 10.1016/j.jvs.2013.06.061.

2.

Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.

Lau WC, Froehlich JB, Jewell ES, Montgomery DG, Eng KM, Shields TA, Henke PK, Eagle KA.

Ann Vasc Surg. 2013 May;27(4):537-45. doi: 10.1016/j.avsg.2012.12.001. Epub 2013 Mar 25.

PMID:
23535525
3.

To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.

Oscarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C.

Br J Anaesth. 2010 Mar;104(3):305-12. doi: 10.1093/bja/aeq003.

PMID:
20150346
4.

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

Berger JS, Brown DL, Becker RC.

Am J Med. 2008 Jan;121(1):43-9. doi: 10.1016/j.amjmed.2007.10.002. Review.

PMID:
18187072
5.

Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention.

Chiu FC, Wang TD, Lee JK, Shih FY, Lin JW, Huang CH, Chen WJ, Chen MF.

Eur J Intern Med. 2011 Oct;22(5):471-7. doi: 10.1016/j.ejim.2011.02.021. Epub 2011 Mar 15.

PMID:
21925055
6.

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome.

Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC.

J Thromb Haemost. 2006 Mar;4(3):542-9. Epub 2005 Dec 22.

7.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

8.

The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.

Ward RP, Leeper NJ, Kirkpatrick JN, Lang RM, Sorrentino MJ, Williams KA.

Int J Cardiol. 2005 Oct 10;104(3):264-8.

PMID:
16186054
9.

Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.

Mardikar H, Deo D, Deshpande N, Mardikar M, Ghosh A, Munot K, Steinhubl S, Mukherjee D.

J Assoc Physicians India. 2008 May;56:321-4.

PMID:
18700638
10.

Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.

Kojuri J, Mahmoody Y, Zangbar Sabegh B, Jannati M, Mahboodi A, Khalili A.

Cardiovasc Ther. 2010 Jun;28(3):147-52. doi: 10.1111/j.1755-5922.2010.00170.x.

PMID:
20557313
11.

Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.

Feringa HH, Bax JJ, Karagiannis SE, Noordzij P, van Domburg R, Klein J, Poldermans D.

Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):116-20. doi: 10.1016/j.archger.2007.11.003. Epub 2008 Jan 4.

PMID:
18177954
12.

The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease.

Cao J, Liu L, Fan L, Chen T, Hu G, Hu Y, Zhu B, Li J, Wang H, Li X.

Aging Male. 2012 Sep;15(3):140-7. doi: 10.3109/13685538.2012.666584. Epub 2012 Mar 27.

PMID:
22452804
13.

Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.

Rajagopalan S, Ford I, Bachoo P, Hillis GS, Croal B, Greaves M, Brittenden J.

J Thromb Haemost. 2007 Oct;5(10):2028-35. Epub 2007 Jul 23.

14.

[Aspirin resistance in patients taking small dose of aspirin].

Wang CB, Hu DY, Shi XB, Zhu ZY, Zhu JY, Yang JG.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Apr;18(4):219-23. Chinese.

15.

[Preoperative analysis of platelet aggregability in carotid surgery].

Morofuji Y, So G, Hiu T, Kawakubo J, Hayashi K, Kitagawa N, Morikawa M, Suyama K, Nagata I.

No Shinkei Geka. 2011 May;39(5):459-63. Japanese.

PMID:
21512195
16.

Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin.

Crescente M, Mezzasoma AM, Del Pinto M, Palmerini F, Di Castelnuovo A, Cerletti C, De Gaetano G, Gresele P.

Platelets. 2011;22(3):179-87. doi: 10.3109/09537104.2010.543710. Epub 2011 Feb 1.

PMID:
21284493
17.

Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.

Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS.

Circulation. 2005 Aug 30;112(9 Suppl):I286-92.

18.

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.

Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ; CHARISMA Investigators.

Eur Heart J. 2007 Sep;28(18):2200-7. Epub 2007 Aug 2.

PMID:
17673448
19.

Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.

Salama MM, Morad AR, Saleh MA, Sabri NA, Zaki MM, ElSafady LA.

J Clin Pharm Ther. 2012 Dec;37(6):630-6. doi: 10.1111/j.1365-2710.2009.01083.x. Epub 2009 Aug 12.

PMID:
23121257

Supplemental Content

Support Center